Earnings History Data for Xenetic Biosciences (XBIO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Xenetic Biosciences

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-11-2024 AH XBIO Xenetic Biosciences 6.00 -0.28 -0.14 0.00 Xenetic Biosciences GAAP EPS of -$0.28, revenue of $614.1M
[11/13/2024 3:46 PM]		 3.70 0.05 
(1.37%)		 3.70 0.05 
(1.37%)		 2.78 - 5.20 15,752 50,000 1,436
13-08-2024 AH XBIO Xenetic Biosciences 5.00 -0.83 -0.83 0.00 3.29 -0.21 
(-6.00%)		 3.01 -0.49 
(-14.00%)		 2.78 - 5.97 40,811 10,000 285
09-05-2024 PM XBIO Xenetic Biosciences, Inc. 5.93 -0.78 -0.79 -0.60 Xenetic Biosciences reports Q1 results
[5/10/2024 9:49 AM]		 3.90 -0.15 
(-3.62%)		 0.0 0.0 
(0.00%)		 2.55 - 5.97 3,376 0 0
21-03-2024 PM XBIO Xenetic Biosciences 7.00 -0.77 -0.87 0.00 Xenetic Biosciences reports FY results
[3/22/2024 8:14 AM]		 3.96 0.01 
(0.35%)		 0.0 0.0 
(0.00%)		 2.55 - 5.97 2,686 10,000 0
10-11-2023 PM XBIO Xenetic Biosciences, Inc. 4.68 -0.69 -1.12 -0.60 Xenetic Biosciences reports Q3 results
[11/10/2023 9:18 AM]		 2.91 -0.04 
(-1.36%)		 0.0 0.0 
(0.00%)		 2.40 - 7.50 5,214 0 0
10-11-2022 PM XBIO Xenetic Biosciences 6.00 -0.06 -0.18 0.00 Xenetic Biosciences GAAP EPS of -$0.06, revenue of $411.95M
[11/10/2022 8:51 AM]		 0.4069 0.02 
(4.33%)		 0.39 0.0 
(0.00%)		 0.36 - 1.76 51,645 70,000 550
12-08-2022 PM XBIO Xenetic Biosciences, Inc. 5.29 -0.19 -0.12 -0.13 Xenetic Biosciences reports Q2 results
[8/12/2022 8:29 AM]		 0.9196 0.04 
(4.50%)		 0.88 -0.01 
(-1.11%)		 0.45 - 4.44 17,102 60,000 396
23-03-2022 PM XBIO Xenetic Biosciences, Inc. 6.42 N/A -0.15 -0.15 Xenetic Biosciences GAAP EPS of -$0.55, revenue of $1.16M
[3/23/2022 9:19 AM]		 1.09 0.04 
(3.81%)		 1.04 -0.01 
(-0.95%)		 0.85 - 5.68 256,558 137,625 9,100
12-11-2021 PM XBIO Xenetic Biosciences, Inc. 10.89 -0.13 -0.12 0.27 Xenetic Biosciences EPS misses by $0.01, beats on revenue
[11/12/2021 8:34 AM]		 1.72 0.05 
(2.99%)		 1.69 0.02 
(1.19%)		 0.82 - 5.85 230,526 210,000 15,952